Crinetics Pharmaceuticals (CRNX)

• Market cap: $4.1B
• 1 day: 0.51%
• 5 days: 5.84%
• 1 month: 4.44%
• 3 months: 52.15%
• 6 months: 30.28%
• Year to date: -15.62%
• 1 year: -22.27%
• 5 years: 252.23%
• 10 years: 77.48%
• Sector: Healthcare
• Industry: Biotechnology

About: Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Employees: 437